Skip to main content
. 2012 Jun 29;7(6):e39625. doi: 10.1371/journal.pone.0039625

Figure 4. MX-induced NK cell maturation is associated with the clinical response.

Figure 4

Thawed PBMCs from SPMS patients stratified into responders and non-responders to MX, were stained for expression of CD62L, CD27, CD57, NKp30, and NKp46 on NK cells. (A) Following 12 months of treatment the responder cohort showed decreased CD62L, NKp46 and NKp30 expression on NK cells. (B) The non-responder cohort did not show any difference in CD62L, NKp46 and NKp30 expression. *p<0.05; mth, months.